Regenxbio
RGNX
RGNX
211 hedge funds and large institutions have $1.73B invested in Regenxbio in 2019 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 92 increasing their positions, 51 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.68% less ownership
Funds ownership: 83.54% → 82.86% (-0.68%)
57% less call options, than puts
Call options by funds: $9.38M | Put options by funds: $21.9M
Holders
211
Holding in Top 10
2
Calls
$9.38M
Puts
$21.9M
Top Buyers
| 1 | +$28.7M | |
| 2 | +$26.8M | |
| 3 | +$15.2M | |
| 4 |
SG Americas Securities
New York
|
+$9.72M |
| 5 |
Bank of New York Mellon
New York
|
+$8.03M |
Top Sellers
| 1 | -$34.3M | |
| 2 | -$21.7M | |
| 3 | -$17.2M | |
| 4 |
Morgan Stanley
New York
|
-$12.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.72M |